Pongdhana K, Ogawa N, Hirose Y, Ono T, Kosaka F, Mori A
Neurochem Res. 1987 Jan;12(1):73-7. doi: 10.1007/BF00971367.
Intraperitoneal injection of ketamine (100 mg/kg body weight) significantly reduces the levels of cholecystokinin (CCK), somatostatin (SRIF), and substance P (SP)-like immunoreactivity in various regions of rat brain. No significant change in thyrotropin releasing hormone (TRH)-like immunoreactivity was observed. Neuropeptide systems may be involved in the neuropharmacologic effects of ketamine.
腹腔注射氯胺酮(100毫克/千克体重)可显著降低大鼠脑不同区域胆囊收缩素(CCK)、生长抑素(SRIF)和P物质(SP)样免疫反应性水平。促甲状腺激素释放激素(TRH)样免疫反应性未观察到显著变化。神经肽系统可能参与了氯胺酮的神经药理作用。